{"name":"Pharmstandard","slug":"pharmstandard","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Arbidol (Umifenovir)","genericName":"Arbidol (Umifenovir)","slug":"arbidol-umifenovir","indication":"Influenza A and B prophylaxis and treatment","status":"marketed"}]}],"pipeline":[{"name":"Arbidol (Umifenovir)","genericName":"Arbidol (Umifenovir)","slug":"arbidol-umifenovir","phase":"marketed","mechanism":"Arbidol inhibits viral fusion by blocking the interaction between viral envelope proteins and host cell membranes, preventing viral entry into cells.","indications":["Influenza A and B prophylaxis and treatment","Acute respiratory viral infections","COVID-19 (in some markets, though efficacy remains debated)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE8xbUxQY0Y2NkNtcXREazZpX2o5SGpleHVNSjJXeXpZajVhTDhxWGYwaGVBVmNSX0RpcGRCVWFzVjA3d09jS1NkbjFJWUJnZEhBOG9fZDhicXhjelJFV2c?oc=5","date":"2026-03-10","type":"pipeline","source":"Forbes","summary":"Viktor Kharitonin - Forbes","headline":"Viktor Kharitonin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNOXFOamw3UUIta2VRQ2FaTkxMWG9aMnV6SnRqd2FBbFQ5N2lsV1p3NnBuQjh0dUVyUmRWMnpRWUd1WF9NZk54T0lqNnk4dUJhaDBzTWo3UEhuelVvTlNHNXF5WXYzdFROR25Yclp6WFhoWm96RHhHMkJ1dFlpSGF5U3Q5OWZYLUtETERwZVg2dngtNTZ3eGdWVFdfMnpZdlU?oc=5","date":"2025-04-24","type":"patent","source":"realnoevremya.com","summary":"American cancer drugs in Russia to be replaced by generics - realnoevremya.com","headline":"American cancer drugs in Russia to be replaced by generics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBXMDdxOE5rYVFzZnFkU0t2NnpabVY2dTZZY09IWlRNYjloZ0VybE5aUjJjTFdLdDdoUXFSV1FvRWsyelBYUTJWQURyVWdIOVh3Q2o0Tk10Tk13d09rV3FwUkl0VUd2UTlTRXJKNFNR0gFyQVVfeXFMTzdlRUNhYTZCY0xwdXBfYzhEZ2lRbVl2ajNkWlduOTNOX01zdzA1VnlPWVRQQU93UzJRemdTeXp3Z0hiOHM0czljOTZOWklZTE93MnVHUlVBcDdtMVZlR1ZXWURjMG1rVFZBcUJtNzhoQVRn?oc=5","date":"2022-02-10","type":"pipeline","source":"koreabiomed.com","summary":"Russia OKs Daewon’s non-steroidal anti-inflammatory drug - koreabiomed.com","headline":"Russia OKs Daewon’s non-steroidal anti-inflammatory drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxONm5saVliUXc0SE41aGJxU0tXWFp3SXdJQms0TDFSVklqRFN0UFE4ei13OUFRQkpjNHhEdld5ckxVaFJKZDVkSDgxZkZmdndFMmFydWhDSW1VSktFbVNuTm9uSmpzdC1pR0hEWGVlMnBmOFQ0d2VlS0NWdWFfVlE0cXEzSi1uTzQwVzFZdnJB?oc=5","date":"2021-06-30","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Biocad to be taken over by Russian investment firm - Generics and Biosimilars Initiative","headline":"Biocad to be taken over by Russian investment firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOTmlTN0NfQVlFSVZOOVJ0emc3T1JmWnUyVUNsaVpiU19Vbk1ZVXlsMWREM2JYRFpqWFd6R1o3TUYtbmxCTnlOd0dzOW1zbEV4RzMxSDJVOHNJaFJZak9TNk4ydjBPOUZlTGNrd21DN1N1OXdqdDZSd1RvX1ZxWFgydzJkb0hPRFNQTUVBNzJsOGIxYWtvcGY4MVdCWHBDYVdSdGVFclpJd3dsTmxIYVQ0aA?oc=5","date":"2018-04-02","type":"pipeline","source":"Caspian News","summary":"Russia Looks To Fast-Track Pharma Products Entering From Japan - Caspian News","headline":"Russia Looks To Fast-Track Pharma Products Entering From Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPU2VFcFFIcGxsQ1NpQ3A2QTB1TEdhTGJIaERIdTBFUGN2Q2ZubnN5eUZ5R3U1d0dHbkl5TXhUN2Uydll3RjN5Z3lldS13cXBxaFFUeVNQZWs3LVE2WThxX3BxTS12V2pkdHhNZ1pOdUZtRnJJeVBXb3pVbmxJQUo4OWkyNS1Wbmc5YjFFdGVfX0tzeDBHV0NKenJEbm5lZmpFbThpcA?oc=5","date":"2017-03-03","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Why Russia’s Pharmaceutical Market Value Will Double in Four Years - drugdiscoverytrends.com","headline":"Why Russia’s Pharmaceutical Market Value Will Double in Four Years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPc3gycldTczlnZ3YwZlV3OXFxcENzT0VhXzFhbEU1Tk5YZE9XdEFySzdjTTBNNDkwM0xVUHFMYkdpcmVzLTMwMnhucWNHNmNlUVRJM0YwWVFhUGpLd2J0Qk1HVW1zdkdTMXBtR2JIQjhvY0JZNWM5dExRRXFNLWh1MTEwa2U5eDVWdF8zNFFHTk1SZ3V6T2FuYkdwbGNHRUY1T1ZVQ284TnZyaEU4NXlVdFZvSy1uZUVBNHc?oc=5","date":"2016-06-21","type":"pipeline","source":"Fierce Pharma","summary":"Eisai launches U.S. Fycompa oral suspension for patients with swallowing problems - Fierce Pharma","headline":"Eisai launches U.S. Fycompa oral suspension for patients with swallowing problems","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQNHVnSjdtMXQxQ3Z4bHdjREpFSkdGd2hJcW5EUGkxc0xncy04SFJvUVJLa0pDU2JjRzJLTUI2TjJVSEVHVUJ5ZU9ocHM1eU11SmpCYWZ0Tnp1YTFkVU4yTG4wMVA4UnJRQ19SLW5YWHRSYXdPUExCUUZlWEt4RXJTdGxTb3hYSUIwMlhCM3d0eHQwQlZzRzRYek1udzBJbzlPcTRJ?oc=5","date":"2016-04-06","type":"pipeline","source":"Fierce Pharma","summary":"Eisai to work with Russia's PharmStandard on oncology manufacture - Fierce Pharma","headline":"Eisai to work with Russia's PharmStandard on oncology manufacture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNMG1UVHJqcGowcEduRkZNOFZ3QXBZdTlkWlZ1aUpmM1pSd1J3SkwzZXlCMnR1dVd6MFdzRFc4ZDJ5SC1oY2s0ZW1qWlhLSkpibVlnN3RzaVRIaW5KLVBCTHd5RmgwM2lqbzJUZ09GcTlWbFlDSjdCTjFHWGhFbmZLMmZ1SGNzX1F5RE5GdVZKZEVrWnBIZXRpVE1lNEhjUQ?oc=5","date":"2014-10-31","type":"deal","source":"The Moscow Times","summary":"Russian Billionaire Victor Kharitonin Buys German F1 Track - The Moscow Times","headline":"Russian Billionaire Victor Kharitonin Buys German F1 Track","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPU3EzbWNSeGNGdDhJRnBfZ0JkY2NGcnlCcGFNNnVMSXdVdWs2Vl85Q0RpZFRkY1pCUUx6ODdQbmJjQnpjcFJ0THlhcTdsQmxrMzVEWHFoV0NrWklxRVpVSzdrblZkWVFaNm16bmNfM0txd242aFZMVnQ2U08yVnF2azNYdGdud1dsSjZTNkRSSWFTQzVlSE1XbC1pdXRTNFhlVW5OZDln?oc=5","date":"2014-08-30","type":"pipeline","source":"celebritynetworth.com","summary":"Viktor Kharitonin Net Worth - celebritynetworth.com","headline":"Viktor Kharitonin Net Worth","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}